All sites C00-96,D32-33,D42-43,D45-47,D76 1846 88.0 4.1 3.2 1.1 3.6
Mouth, pharynx C00-14 28 99.3 - 0.7 - -
  Lip C00 5 100.0 - - - -
  Tongue C02 6 100.0 - - - -
  Mouth, other C03-06 9 100.0 - - - -
  Salivary glands C07-08 3 93.8 - 6.3 - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 344 77.6 7.2 7.5 1.9 5.8
  Oesophagus C15 9 95.6 - - 4.4 -
  Stomach C16 31 94.8 1.9 1.3 1.3 0.6
  Small intestine C17 7 94.3 - - 2.9 2.9
  Colon C18 121 93.7 0.5 2.5 0.5 2.8
  Rectum, rectosigmoid C19-20 44 98.6 - 0.5 - 0.9
  Anus C21 4 95.0 5.0 - - -
  Liver C22 21 69.2 8.4 14.0 0.9 7.5
  Gallbladder, bile ducts C23-24 24 50.8 18.9 13.9 4.1 12.3
  Pancreas C25 71 43.4 22.1 19.6 3.6 11.2
  Other digestive organs C26 12 37.9 10.3 15.5 10.3 25.9
Respiratory organs C30-39 120 60.6 19.6 9.5 3.2 7.2
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 115 59.4 20.6 9.6 3.3 7.1
  Mediastinum, pleura C38 2 50.0 - 25.0 - 25.0
Bone C40-41 2 81.8 - 9.1 - 9.1
Melanoma of the skin C43 49 98.8 0.8 - - 0.4
Skin, non-melanoma C44 89 100.0 - - - -
Mesothelioma C45 3 93.3 6.7 - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 14 98.5 1.5 - - -
Breast C50 558 98.8 0.5 0.2 0.2 0.4
Female genital organs C51-58 204 94.1 2.0 1.5 1.1 1.4
  Cervix uteri C53 23 96.5 0.9 0.9 0.9 0.9
  Corpus uteri C54 102 98.6 0.4 0.4 - 0.6
  Uterus, other C55,C58 2 22.2 11.1 11.1 33.3 22.2
  Ovary C56 52 88.1 4.2 3.1 1.9 2.7
  Other female genital C51-52,C57 26 91.5 3.8 2.3 1.5 0.8
Urinary organs C64-68 83 92.6 1.4 3.1 0.2 2.6
  Kidney C64 52 91.6 1.9 3.1 0.4 3.1
  Bladder and urinary tract2 C65-68 31 94.2 0.6 3.2 - 1.9
Eye C69 1 85.7 14.3 - - -
Brain, central nervous system C70-72,D32-33,D42-43 74 81.2 - 8.9 0.8 9.1
Thyroid gland C73 67 97.3 2.4 - - 0.3
Other endocrine glands C74-75 2 72.7 - 9.1 - 18.2
Illdefined or unknown C76,C80 44 46.8 17.3 13.2 7.3 15.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 163 80.7 5.4 2.0 1.3 10.6
  Hodgkin lymphoma C81 7 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 66 97.6 - - 0.3 2.1
  Malignant immunoproliferative diseases C88 1 60.0 - 20.0 - 20.0
  Myeloma and other plasma cell tumors C90 29 68.7 9.5 4.8 2.0 15.0
  Leukaemia C91-95 39 77.6 10.2 3.1 1.0 8.2
  Myelodysplastic syndromes D46 8 45.2 14.3 4.8 2.4 33.3
  Myeloproliferaitive neoplasms D45,D47 12 41.4 6.9 - 6.9 44.8
Not included above
  Carcinoma in situ of the breast D05 52 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 150 100.0 - - - -
  Borderline tumour of the ovary D39 22 94.5 - - - 5.5
  Basal cell carcinoma of the skin 503 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.